Medical News

RSS

Allenex to sell its holding in AnaMar AB to Koncentra Holding

Allenex has agreed to sell its holding in AnaMar AB to the company's main owner Koncentra Holding. The price is set to 1,7 mkr. Allenex became an owner in AnaMar 1998.

3 Jun 2013

Aaxillary lymph node dissection and radiotherapy provide excellent regional control for patients with breast cancer

Final analysis of the EORTC 10981-22023 AMAROS (After Mapping of the Axilla: Radiotherapy Or Surgery?) trial has shown that both axillary lymph node dissection and axillary radiotherapy provide excellent regional control for breast cancer patients with a positive sentinel node biopsy

3 Jun 2013

Lupus Foundation of America announces Career Development Award and new summer fellowships

The Lupus Foundation of America, the only national force dedicated to solving the cruel mystery of lupus, announced recipients of five new summer fellowships and the Foundation's first-ever Career Development Award.

3 Jun 2013

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

The criteria used to diagnose both circulatory and brain death in a patient are subject to variability and as such can be controversial. Anaesthesiologists play an important role in procedures related to the determination of death, so should have specific knowledge about medical, ethical and legal criteria of brain death definition.

3 Jun 2013

New approach to beef trade could positively transform livelihoods for farmers, reduce threat to wildlife movements

A new study by the Wildlife Conservation Society's Animal & Human Health for the Environment And Development (AHEAD) Program, World Wildlife Fund (WWF), and regional partners finds that a new approach to beef production in southern Africa could positively transform livelihoods for farmers and pastoralists, while helping to secure a future for wildlife and wildlife-based tourism opportunities.

3 Jun 2013

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that its SGX942 development program for the treatment of oral mucositis as a result of radiation and/or chemotherapy treatment in head and neck cancer patients has received "Fast Track" designation from the US Food and Drug Administration.

3 Jun 2013

Mathematical modeling proved critical in understanding latent stage of infections

Recurrent infection is a common feature of persistent viral diseases. It includes episodes of high viral production interspersed by periods of relative quiescence. These quiescent or silent stages are hard to study with experimental models. Mathematical analysis can help fill in the gaps.

3 Jun 2013

Arcturus Therapeutics closes $1.3 M in seed funding round

Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of disease, today announced it has raised $1.3 million in a seed funding round led by multiple high net-worth private investors from the United States and Canada.

3 Jun 2013

NewLink Genetics announces results from two clinical studies with indoximod

NewLink Genetics Corporation, an oncology-focused biopharmaceutical company specializing in immunotherapy, today announced results from two clinical studies with indoximod, an orally administered small molecule drug candidate that inhibits the IDO pathway.

3 Jun 2013

Shire resolves patent infringement lawsuit against Teva relating to INTUNIV tablet

Shire LLC has settled its litigation against Teva Pharmaceuticals USA Inc. ("Teva") in connection with Teva's Abbreviated New Drug Application ("ANDA") for a generic version of Shire's INTUNIV (guanfacince) Extended Release Tablets for the treatment of Attention Deficit Hyperactivity Disorder.

3 Jun 2013

Amgen reports encouraging results from talimogene laherparepvec phase 3 study in patients with metastatic melanoma

Amgen today announced detailed results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).

3 Jun 2013

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced clinical data demonstrating the utility of VB-111's in targeted cancer treatment.

3 Jun 2013

Researchers reveal how disease mutations affect the stability and function of Parkin protein

Researchers at the MRC Laboratory of Molecular Biology in the United Kingdom have determined the crystal structure of Parkin, a protein found in cells that when mutated can lead to a hereditary form of Parkinson's disease.

3 Jun 2013

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from the combined data analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Arimidex, Tamoxifen, Alone or in Combination studies.

From NanoString Technologies 3 Jun 2013

A national summit to boost education and employment outcomes for Americans with disabilities

Elaine Katz, MS, CCC-SLP, of Kessler Foundation will speak at "Building a More Inclusive Workforce: A National Summit to Boost Education and Employment Outcomes for Americans with Disabilities."

3 Jun 2013

Red Hat receives CEO Cancer Gold Standard accreditation for workplace actions to reduce cancer

Red Hat, the world's leading provider of open source software solutions, headquartered in Raleigh, NC, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior.

3 Jun 2013

Study shows only few junior athletes have seen success as senior athletes

An Indiana University study that compared the performance of elite track and field athletes younger than 20 and those 20 and older found that only a minority of the star junior athletes saw similar success as senior athletes.

3 Jun 2013

First Edition: June 3, 2013

Today's early morning highlights from major news organizations, including a number of stories detail health law implementation developments.

3 Jun 2013

GRACE study reports colored women are poorly represented in HIV drug trials

Enrollment of women in clinical trials of new anti-HIV drugs is extremely low, representing only about 15% of all treatment-experienced patients. For women of color it is even lower.

3 Jun 2013

The Tower Companies commits to provide support for fifth annual National Employee Wellness Month

THE TOWER COMPANIES today announced it has pledged support for, and will participate in, the fifth annual National Employee Wellness Month. This month-long initiative helps business leaders learn from best practices of how to successfully engage employees in healthy lifestyles.

3 Jun 2013

Medical News

Allenex to sell its holding in AnaMar AB to Koncentra Holding

Aaxillary lymph node dissection and radiotherapy provide excellent regional control for patients with breast cancer

Lupus Foundation of America announces Career Development Award and new summer fellowships

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

New approach to beef trade could positively transform livelihoods for farmers, reduce threat to wildlife movements

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

Mathematical modeling proved critical in understanding latent stage of infections

Arcturus Therapeutics closes $1.3 M in seed funding round

NewLink Genetics announces results from two clinical studies with indoximod

Shire resolves patent infringement lawsuit against Teva relating to INTUNIV tablet

Amgen reports encouraging results from talimogene laherparepvec phase 3 study in patients with metastatic melanoma

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

Researchers reveal how disease mutations affect the stability and function of Parkin protein

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

A national summit to boost education and employment outcomes for Americans with disabilities

Red Hat receives CEO Cancer Gold Standard accreditation for workplace actions to reduce cancer

Study shows only few junior athletes have seen success as senior athletes

First Edition: June 3, 2013

GRACE study reports colored women are poorly represented in HIV drug trials

The Tower Companies commits to provide support for fifth annual National Employee Wellness Month

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News